Toronto, Ontario — Eyecarrot Innovations Corp. (TSX-V: EYC) is pleased to announce the appointment of Adam Cegielski, Founder of Eyecarrot, as President and CEO, effective immediately. The appointment reflects a deeper commitment to the company’s product and technology strategy, which will allow the team to move more quickly to market. With an educational background in applied biochemistry, global experience as a serial entrepreneur, and the vision and motivation to revolutionize vision science stemming from his son’s binocular vision issues, Mr. Cegielski will provide clear leadership and direction to help the company achieve its goals.
Eyecarrot also announced today that by mutual agreement, Eyecarrot and Guelph Vision Therapy Center (“GVTC”) have decided not to pursue a transaction at this time and will instead work together to further refine Eyecarrot’s strategy for scaling the data acquisition model. Dr. Patrick Quaid, will continue in his role as Chief Scientific Officer (Binocular Vision) for Eyecarrot, providing valuable guidance and direction on the company’s product and clinical partnership strategies.
“I look forward to working with Eyecarrot to advance the opportunity presented by real-time data tracking capabilities and how they apply to our advanced clinical model. We at GVTC are excited to continue to focus on our significant year-over-year growth, and move forward with expanding on our current strategy”
The company also announced that Dr. Brent Norton MD has resigned as President, Chief Executive Officer and Director of the company. Eyecarrot would like to wish Dr. Norton well on his future endeavours, and thanks him for his past contributions to moving the company forward.
“Together, these announcements highlight and recognize Eyecarrot’s relentless focus on building a universally-available technology platform to set the global standard for binocular vision care,” said Adam Cegielski, Founder and CEO of Eyecarrot.
Eyecarrot’s Binovitm platform is an innovative healthcare technology solution that integrates software, hardware, data and expert knowledge. Binovi helps Optometrists treat vision issues with in-office therapy as well as doctor led home based activities to better serve and increase the patient’s experience and their therapy needs. The goal is to help transform vision performance for the 1 in 4 people worldwide that suffer from vision-related issues going beyond visual acuity. The company is transforming how vision healthcare services are integrated, while addressing key challenges in the health system.
Forward Looking Information
Certain statements contained in this news release constitute "forward-looking information" as such term is used in applicable Canadian securities laws. Forward-looking information is based on plans, expectations, and estimates of management at the date the information is provided and is subject to certain factors and assumptions, including, that the Company's financial condition and development plans do not change as a result of unforeseen events and that the Company obtains regulatory approval. Forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause plans, estimates and actual results to vary materially from those projected in such forward-looking information. Factors that could cause the forward-looking information in this news release to change or to be inaccurate include, but are not limited to, the risk that any of the assumptions referred to prove not to be valid or reliable, that occurrences such as those referred to above are realized and result in delays, or cessation in planned work, that the Company's financial condition and development plans change, and delays in regulatory approval, as well as the other risks and uncertainties applicable to the Company as set forth in the Company's continuous disclosure filings filed under the Company's profile at www.sedar.com . The Company undertakes no obligation to update these forward-looking statements, other than as required by applicable law.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
source Eyecarrot Innovations Corp.